Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $46,794. The most recent transaction as insider was on Dec 21, 2022, when has been sold 8,000 shares (Common Stock) at a price of $113.08 per share, resulting in proceeds of $904,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130

0% 3M change

0% 12M change

Total Value Held $46,794

MARTINE A ROTHBLATT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 21 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 20 2022	SELL Open market or private sale	$2,175,920 $271.99 p/Share	8,000 Reduced 98.4%	130 Common Stock
Dec 20 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 19 2022	SELL Open market or private sale	$2,187,680 $273.46 p/Share	8,000 Reduced 98.4%	130 Common Stock
Dec 19 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 16 2022	SELL Open market or private sale	$2,218,240 $277.28 p/Share	8,000 Reduced 98.4%	130 Common Stock
Dec 16 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 15 2022	SELL Open market or private sale	$2,195,520 $274.44 p/Share	8,000 Reduced 98.4%	130 Common Stock
Dec 15 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 14 2022	SELL Open market or private sale	$1,750,078 $277.35 p/Share	6,310 Reduced 97.98%	130 Common Stock
Dec 14 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 13 2022	SELL Open market or private sale	$2,697,308 $278.36 p/Share	9,690 Reduced 83.33%	1,939 Common Stock
Dec 13 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 12 2022	SELL Open market or private sale	$2,233,200 $279.15 p/Share	8,000 Reduced 98.4%	130 Common Stock
Dec 12 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 09 2022	SELL Open market or private sale	$2,244,400 $280.55 p/Share	8,000 Reduced 98.4%	130 Common Stock
Dec 09 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 08 2022	SELL Open market or private sale	$2,229,760 $278.72 p/Share	8,000 Reduced 98.4%	130 Common Stock
Dec 08 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 07 2022	SELL Open market or private sale	$2,204,160 $275.52 p/Share	8,000 Reduced 98.4%	130 Common Stock
Dec 07 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 06 2022	SELL Open market or private sale	$2,192,480 $274.06 p/Share	8,000 Reduced 98.4%	130 Common Stock
Dec 06 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Dec 05 2022	SELL Open market or private sale	$2,167,360 $270.92 p/Share	8,000 Reduced 98.4%	130 Common Stock
Dec 05 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock

MAR

Martine A Rothblatt

Chairperson & CEO

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account